Table 2.
PI-RADS v2 and biopsy results of study participants.
| Characteristic | Overall | PCa | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total (n = 756) | Benign+low/intermediate-grade PCa (n = 552) | High-grade PCa (n = 204) | Z | P-value | Urban (n = 223) | Rural (n = 207) | Z | P-value | |
| PI-RADS v2 | −12.955 | <0.001 | −1.274 | 0.203 | |||||
| 1–2 | 153 (20.2%) | 151 (27.4%) | 2 (1.0%) | 7 (3.1%) | 3 (1.4%) | ||||
| 3 | 237 (31.4%) | 204 (40.0%) | 33 (16.2%) | 49 (22.0%) | 41 (19.8%) | ||||
| 4 | 211 (27.9%) | 138 (25.0%) | 73 (35.8%) | 87 (39.0%) | 78 (37.7%) | ||||
| 5 | 155 (20.5%) | 59 (10.7%) | 96 (47.1%) | 80 (35.9%) | 85 (41.1%) | ||||
| Biopsy results | −22.131 | <0.001 | −8.192 | <0.001 | |||||
| Benign | 326 (43.1%) | 326 (59.1) | |||||||
| ISUP 1 | 44 (5.8%) | 44 (8.0%) | 36 (16.1%) | 8 (3.9%) | |||||
| ISUP 2 | 86 (11.4%) | 86 (15.6%) | 62 (27.8%) | 24 (11.6%) | |||||
| ISUP 3 | 96 (12.7%) | 96 (17.4%) | 59 (26.5%) | 37 (17.9%) | |||||
| ISUP 4 | 109 (14.4%) | 109 (53.4%) | 42 (18.8%) | 67 (32.4%) | |||||
| ISUP 5 | 95 (12.6%) | 95 (46.6%) | 24 (10.8%) | 71 (34.3%) | |||||
ISUP, International Society of Urological Pathology.